Impact of peritoneal dialysis-related peritonitis on PD discontinuation and mortality: A population-based national cohort study.


Journal

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
ISSN: 1718-4304
Titre abrégé: Perit Dial Int
Pays: United States
ID NLM: 8904033

Informations de publication

Date de publication:
03 2022
Historique:
pubmed: 9 6 2021
medline: 27 4 2022
entrez: 8 6 2021
Statut: ppublish

Résumé

The impact of peritoneal dialysis-associated peritonitis (PD peritonitis) on long-term outcomes is uncertain. This nationwide retrospective study was conducted in Taiwan to understand the incidence, risk factors and long-term outcomes of PD peritonitis. A total of 11,202 incident adult peritoneal dialysis (PD) patients from 2000 to 2010 were collected from a Longitudinal Health Insurance Database and followed up until the end of 2011. Definition of peritonitis, the primary outcome, simultaneously met the diagnosis of peritonitis (International Classification of Diseases, Ninth Revision, Clinical Modification 567) and antibiotic use. Secondary outcomes included the impact of peritonitis on PD discontinuation and survival. Cox proportional hazards models with and without time-dependent variables were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). There were 7634 peritonitis episodes in 4245 patients during the follow-up period. The overall incidence of peritonitis was 0.18 episodes per patient-year. Peritonitis-associated risk factors included older age, female gender, chronic heart failure, cerebrovascular disease, liver cirrhosis and lower monthly income. In an adjusted Cox hazard proportional regression with the time-dependent model, peritonitis patients had a higher risk of PD discontinuation (HR 2.71, 95% CI 2.52-2.92) and mortality (HR 1.68, 95% CI 1.57-1.81) compared to patients without peritonitis. The adjusted HRs for mortality increased with each prior episode: one episode, two episodes and more than two episodes (all Although peritonitis incidence was low, our findings reveal that peritonitis carried acute and long-term sequelae of higher PD discontinuation and lower patient survival.

Sections du résumé

BACKGROUND
The impact of peritoneal dialysis-associated peritonitis (PD peritonitis) on long-term outcomes is uncertain. This nationwide retrospective study was conducted in Taiwan to understand the incidence, risk factors and long-term outcomes of PD peritonitis.
METHODS
A total of 11,202 incident adult peritoneal dialysis (PD) patients from 2000 to 2010 were collected from a Longitudinal Health Insurance Database and followed up until the end of 2011. Definition of peritonitis, the primary outcome, simultaneously met the diagnosis of peritonitis (International Classification of Diseases, Ninth Revision, Clinical Modification 567) and antibiotic use. Secondary outcomes included the impact of peritonitis on PD discontinuation and survival. Cox proportional hazards models with and without time-dependent variables were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).
RESULTS
There were 7634 peritonitis episodes in 4245 patients during the follow-up period. The overall incidence of peritonitis was 0.18 episodes per patient-year. Peritonitis-associated risk factors included older age, female gender, chronic heart failure, cerebrovascular disease, liver cirrhosis and lower monthly income. In an adjusted Cox hazard proportional regression with the time-dependent model, peritonitis patients had a higher risk of PD discontinuation (HR 2.71, 95% CI 2.52-2.92) and mortality (HR 1.68, 95% CI 1.57-1.81) compared to patients without peritonitis. The adjusted HRs for mortality increased with each prior episode: one episode, two episodes and more than two episodes (all
CONCLUSIONS
Although peritonitis incidence was low, our findings reveal that peritonitis carried acute and long-term sequelae of higher PD discontinuation and lower patient survival.

Identifiants

pubmed: 34100316
doi: 10.1177/08968608211018949
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

194-203

Auteurs

Mu-Chi Chung (MC)

Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital.
Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung.
Rong Hsing Research Center For Translational Medicine, National Chung Hsing University, Taichung.

Tung-Min Yu (TM)

Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital.

Ming-Ju Wu (MJ)

Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital.

Ya-Wen Chuang (YW)

Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital.

Chih-Hsin Muo (CH)

Management Office for Health Data, China Medical University and Hospital, Taichung.

Cheng-Hsu Chen (CH)

Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital.

Shih-Ting Huang (ST)

Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital.

Chi-Yuan Li (CY)

Graduate Institute of Biomedical Sciences and School of Medicine, College of Medicine, China Medical University, Taichung.

Jeng-Jer Shieh (JJ)

Rong Hsing Research Center For Translational Medicine, National Chung Hsing University, Taichung.
Institute of Biomedical Sciences, National Chung Hsing University, Taichung.
Department of Education and Research, Taichung Veterans General Hospital.

Peir-Haur Hung (PH)

Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi.
Department of Applied Life Science and Health, Chia-Nan University of Pharmacy and Science, Tainan.

Chi-Jung Chung (CJ)

Department of Public Health, College of Public Health, China Medical University, Taichung.
Department of Medical Research, China Medical University Hospital, Taichung.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH